Pancreatic Diseases  >>  oxaliplatin  >>  Phase 2
Welcome,         Profile    Billing    Logout  

16 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
oxaliplatin / Generic mfg.
NCT00004190: Gemcitabine Plus Oxaliplatin in Treating Patients With Refractory Locally Advanced or Metastatic Pancreatic Cancer

Completed
2
59
US, Canada
gemcitabine hydrochloride, oxaliplatin
Alliance for Clinical Trials in Oncology, National Cancer Institute (NCI)
Pancreatic Cancer
04/03
06/03
NCT00096070: Radiotherapy Combined With Oxaliplatin and Fluorouracil Followed By Gemcitabine in Treating Patients With Locally Advanced, Unresectable Pancreatic Cancer

Completed
2
50
US
radiation therapy, irradiation, radiotherapy, therapy, radiation, oxaliplatin, 1-OHP, Dacotin, Dacplat, Eloxatin, L-OHP, fluorouracil, 5-fluorouracil, 5-Fluracil, 5-FU, gemcitabine hydrochloride, dFdC, difluorodeoxycytidine hydrochloride, gemcitabine, Gemzar
National Cancer Institute (NCI)
Adenocarcinoma of the Pancreas, Stage II Pancreatic Cancer, Stage III Pancreatic Cancer
04/07
 
NCT00222469: Combination Chemotherapy for 1st Line Treatment of Advanced or Metastatic Pancreatic Cancer

Completed
2
50
US
bevacizumab, gemcitabine, oxaliplatin
University of Oklahoma, Genentech, Inc., Sanofi, M.D. Anderson Cancer Center
Metastatic Pancreatic Cancer
05/07
05/07
NCT00564720: Gemcitabine Plus Erlotinib Versus Erlotinib Plus Gemcitabine Plus Oxaliplatin, in Pancreatic Cancer

Terminated
2
140
Europe
Gemcitabine, Gemzar, Erlotinib, Tarceva, Oxaliplatin, Eloxatin
Hellenic Oncology Research Group, University Hospital of Crete
Pancreatic Cancer
03/11
03/11
NCT00536874: Gemcitabine and Oxaliplatin in Treating Patients With Pancreatic Cancer That Can Be Removed By Surgery

Completed
2
39
US
gemcitabine hydrochloride, oxaliplatin, protein expression analysis, proteomic profiling, diagnostic laboratory biomarker analysis, adjuvant therapy, neoadjuvant therapy, therapeutic conventional surgery
Memorial Sloan Kettering Cancer Center, National Cancer Institute (NCI)
Pancreatic Cancer
09/12
02/17
NCT01505413: Phase 2 Study of Erlotinib, Gemcitabine and Oxaliplatin Combination Chemotherapy to Advanced Pancreatic Cancer

Checkmark ASCO 2014
May 2014 - May 2014: ASCO 2014
Completed
2
33
RoW
Erlotinib, tarceva, Gemcitabine, gemza, gemcibine, Oxaliplatin, oxalitin
Soonchunhyang University Hospital
Pancreatic Cancer
12/13
03/14
NCT00609336: Perioperative Therapy for Resectable Pancreatic Cancer

Completed
2
35
US
gemcitabine hydrochloride, dFdC, difluorodeoxycytidine hydrochloride, gemcitabine, Gemzar, docetaxel, RP 56976, Taxotere, TXT, capecitabine, CAPE, Ro 09-1978/000, Xeloda, intensity-modulated radiation therapy, IMRT, oxaliplatin, 1-OHP, Dacotin, Dacplat, Eloxatin, L-OHP, pancreatic surgical procedure, pancreatic surgery, therapeutic conventional surgery, laboratory biomarker analysis
University of Washington, National Cancer Institute (NCI)
Adenocarcinoma of the Pancreas, Stage IA Pancreatic Cancer, Stage IB Pancreatic Cancer, Stage IIA Pancreatic Cancer, Stage IIB Pancreatic Cancer
11/14
12/16
NCT00871169: Combination of Irinotecan, Oxaliplatin and Cetuximab for Locally Advanced or Metastatic Pancreatic Cancer

Completed
2
61
US
Irinotecan, oxaliplatin, and cetuximab, Eloxatin, ERBITUX
New Mexico Cancer Care Alliance
Pancreatic Cancer
04/15
04/15
SWOG-S1115, NCT01658943: Selumetinib and Akt Inhibitor MK2206 or mFOLFOX Therapy Comprising Oxaliplatin and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer Previously Treated With Chemotherapy

Checkmark ASCO 2015
May 2015 - May 2015: ASCO 2015
Checkmark ASCO 2013
May 2013 - May 2013: ASCO 2013
Completed
2
137
US
Akt Inhibitor MK2206, MK2206, Fluorouracil, 5-Fluoro-2,4(1H, 3H)-pyrimidinedione, 5-Fluorouracil, 5-Fluracil, 5-FU, AccuSite, Actino-Hermal, Adrucil, Arumel, Cytosafe, Efudex, Efurix, Fiverocil, Fluoro Uracil, Fluoroplex, Fluouracil, Flurablastin, Fluracedyl, Fluracil, Fluril, Fluroblastin, Flurox, Ribofluor, Ro 2-9757, Ro-2-9757, Timazin, Oxaliplatin, 1-OHP, Dacotin, Dacplat, Diaminocyclohexane Oxalatoplatinum, Eloxatin, Eloxatine, JM-83, Oxalatoplatin, Oxalatoplatinum, RP 54780, RP-54780, SR-96669, Selumetinib, ARRY-142886, AZD6244, MEK Inhibitor AZD6244
National Cancer Institute (NCI)
Pancreatic Acinar Cell Carcinoma, Pancreatic Ductal Adenocarcinoma, Recurrent Pancreatic Carcinoma, Stage IV Pancreatic Cancer
06/15
06/15
NCT01488552: Gemcitabine+Nab-paclitaxel and FOLFIRINOX and Molecular Profiling for Patients With Advanced Pancreatic Cancer

Completed
2
60
US
Gemcitabine, Gemzar, nab-paclitaxel, Abraxane, FOLFIRINOX, 5-FU, Eloxitan, Campostar, Immunohistochemistry (IHC) Analysis, Metformin, Glucophage, mFOLFIRI
Pancreatic Cancer Research Team
Stage IV Pancreatic Cancer
08/15
08/16
NCT01688336: FOLFIRINOX for Unresectable Locally Advanced and Borderline Resectable Pancreatic Cancer

Terminated
2
9
US
FOLFIRINOX, FOLFIRINOX is a chemotherapy regimen comprised of the following drugs, given in combination, -Oxaliplatin, -Leucovorin, -Irinotecan, -5FU
UNC Lineberger Comprehensive Cancer Center
Pancreatic Cancer
08/16
11/16
NCT02035072 / 2010-020379-22: Phase II Study of Hypofractionated Radio-chemotherapy With Gemcitabine Plus Oxaliplatin for Unresectable Nonmetastatic Locally Advanced Pancreatic Cancer.

Completed
2
40
Europe
Gemcitabine, Oxaliplatin, oxalipaltin, Hypofractionated RT
Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori
Unresectable Pancreatic Cancer, Nonmetastatic Pancreatic Cancer, Locally Advanced Pancreatic Cancer
12/16
12/16
NCT02195180 / 2013-004262-34: Efficacy and Safety of L-asparaginase Encapsulated in RBC Combined With Gemcitabine or FOLFOX in 2nd Line for Progressive Metastatic Pancreatic Carcinoma

Completed
2
141
Europe
ERY001, L asparaginase encapsulated in erythrocytes, Gemcitabine, 5-fluoro-uracil/oxaliplatin/leucovorin (folfox)
ERYtech Pharma
Pancreatic Adenocarcinoma Metastatic
02/17
11/17
NCT00242190: Gemcitabine, Oxaliplatin and Radiation Therapy in Pancreatic Cancer

Completed
1/2
40
US
oxaliplatin, gemcitabine, radiation therapy
University of Michigan Rogel Cancer Center, Sanofi-Synthelabo
Pancreatic Neoplasms
03/06
02/10
GEMOXEL, NCT00744640: Gemcitabine, Oxaliplatin and Capecitabine for Advanced Pancreatic Carcinoma

Checkmark Data ASCO
Jun 2012 - Jun 2012: Data ASCO
Checkmark Data
Jan 2012 - Jan 2012: Data
Completed
1/2
46
Europe
gemcitabine, oxaliplatin, capecitabine
University Hospital, Basel, Switzerland, Swiss National Science Foundation, Swiss Cancer League, Roche Pharma AG, Sanofi
Locally Advanced Pancreatic Cancer, Metastatic Pancreatic Cancer
02/09
12/09
NCT00463840: Chemoradiation With Oxaliplatin and Fluorouracil (5FU) for Locally Advanced Pancreatic Cancer

Terminated
1/2
24
US
Oxaliplatin, Oxaliplatin: Eloxatin, 5FU, 5-Fluorouracil, Radiation, Surgery, FOLFOX 6
NYU Langone Health, Sanofi
Pancreatic Cancer
07/10
10/15

Download Options